Autoimmune liver diseases (AILDs), including autoimmune hepatitis, primary biliary cholangitis, primary sclerosing ...
We read with interest the Rome Foundation paediatric global study by Nurko and colleagues,1 which establishes a multinational ...
Background The impact of circulating tumour DNA (ctDNA) detection, which informs minimal residual disease (MRD) after ...
5 State Key Laboratory of Multi-organ Injury Prevention and Treatment, Southern Medical University, Guangzhou, China 6 Guangdong Provincial Key Laboratory of Chinese Medicine Ingredients and Gut ...
Background Advances in systemic therapy for advanced hepatocellular carcinoma (HCC) have fuelled a growing interest in ...
Metastatic pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest solid cancers, portending poor patient outcomes ...
Background Hospitalisations represent major clinical events in cirrhosis, yet prediction based on clinical variables alone ...
Background Pain in chronic pancreatitis (CP) is multifactorial. Efficacy of pancreatic enzyme replacement therapy (PERT) for pain remains uncertain. Objective To assess the effect of ...
The recent conditional US Food and Drug Administration (FDA) approval of two therapies, resmetirom (Rezdiffra) and semaglutide (Wegovy), marks the first time clinicians have pharmacological therapy ...
Correspondence to Dr Bruno Ramos-Molina; brunoramosmolina{at}gmail.com; Dr Mohammad Shafi Kuchay; drshafikuchay{at}gmail.com Contributors Conceptualisation: MSK and BR-M. Writing—original draft ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results